Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APART: Active Preoperative Anemia Management to Reduce Erythrocyte Transfusion in Patients Undergoing Cardiac Surgery
NCT02189889Phase 2Terminated
- Sponsor
- UT Southwestern Medical Center
- Start
- Apr 2013
- Primary completion
- Jul 2019
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of epoetin alfa, ferumoxytol in anemia, sponsored by UT Southwestern Medical Center. Started Apr 2013; status: terminated.
02
Drugs
epoetin alfaferumoxytol
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02189889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02189889.